Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor βreceptor (PDGFβR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2)

Blood

Volumn 91, Issue 12, 1998, Pages 4419-4426

  Ross, Theodora S ^b   Bernard, Olivier A ^b   Berger, Roland ^b   Gilliland, D Gary ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HUNTINGTIN; HYBRID PROTEIN; INTERLEUKIN 3; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE;

ADULT; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME TRANSLOCATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; GENE FUSION; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SOUTHERN BLOTTING;

EID: 0031864246     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.12.4419.412k43_4419_4426     Document Type: Article

References (33)

1. Peelers P, Wlodarska I, Baens M, Criel A, Selleslag D, Hagemeijer A, Van den Berghe H, Marynen P: Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. Cancer Res 57:564, 1997
2. Rowley J, Reshmi S, Sobulo O, Musvee T, Anastasi J, Raimondi S, Schneider N, Barredo J, Cantu E, Schlegelberger B, Behm F, Doggett N, Borrow J, Zeleznik L: All patients with t(11;16)(q23;p23.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood 90:535, 1997
3. Raynaud SD, Baens M, Grosgeorge J, Rodgers K, Reid CD, Dainton M, Dyer M, Fuzibet JG, Gratecos N, Taillan B, Ayraud N, Marynen P: Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): A recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. Blood 88:682, 1996
4. Yoneda-Kato N, Look AT, Kirstein MN, Valentine MB, Raimondi SC, Cohen KJ, Carroll AJ, Morris SW: The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene 12:265, 1996
5. Peeters P, Raynaud SD, Cools J, Wlodarska I, Grosgeorge J, Philip P, Monpoux F, Van Rompaey L, Baens M, Van den Berghe H, Marynen P: Fusion of TEL, the ETS-variant gene 6 (ETV6) to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 90:2535, 1997
6. Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307, 1994
7. de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, Stephenson JR: A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300:765, 1982
8. Groffen J, Heisterkamp N, Reynolds FH Jr, Stephenson JR: Homology between phosphotyrosine acceptor site of human c-abl and viral oncogene products. Nature 304:167, 1983
9. Golub TR, Goga A, Barker GF, Afar DE, McLaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG: Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol Cell Biol 16:4107, 1996
10. Lacronique V, Boureaux A, Delia Valle V, Poirel H, Tran Quang C, Maucharffe M, Berthou C, Lessard M, Berger R, Ghysdael J, Bernard O: ATEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278:1309, 1997
11. Abe A, Emi N, Mitsune T, Hiroshi T, Marunouchi T, Hidehiko S: Fusion of the platelet-derived growth factor receptor beta to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution. Blood 90:4271, 1997
12. Donis-Keller H: The RET proto-oncogene and cancer. J Intern Med 238:319, 1995
13. Heffelfinger SC, Lower EE, Miller MA, Fenoglio-Preiser CM: Plasma membrane phosphotyrosine, Her2-NEU, and epidermal growth factor receptor in human breast cancer. A comparative study. Am J Clin Oncol 19:552, 1996
14. Knezevich SR, McFadden DE, Tao W, Lim JF, Sorensen PHB: A novel ETV-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet 18:184, 1998
15. Carroll M, Tomasson MH, Barker GF, Golub TR, Gilliland DG: The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associate s and activates PDGF beta R kinase-dependent signaling pathways. Proc Natl Acad Sci USA 93:14845, 1996
16. Bell GI, Karam JH, Rutter WJ: Polymorphic DNA region adjacent to the 5′ end of the human insulin gene. Proc Natl Acad Sci USA 78:5759, 1981
17. Morris SW, Foust J, Valentin M, Roberts W, Shapiro DN, Look AT: Sublocalization of the chromosome 5 breakpoint of the 3;5 translocation in myelodysplastic syndromes and acute myeloid leukemia. Genes Chromosom Cancer 5:385, 1992
18. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
19. Frohman M: Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: Thermal RACE. Methods Enzymol 218:340, 1993
20. Kalchman MA, Koide HB, McCutcheon K, Graham RK, Nichol K, Nishiyama K, Kazemi-Esfarjani P, Lynn FC, Wellington C, Metzler M, Goldberg YP, Kanazawa I, Gietz RD, Hayden MR: HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nat Genet 16:44, 1997
21. Wanker EE, Rovira C, Scherzinger E, Hasenbank R, Walter S, Tait D, Colicelli J, Lehrach H: HIP-I: A huntingtin interacting protein isolated by the yeast two-hybrid system. Hum Mol Genet 6:487, 1997
22. Kazlauskas A, Cooper JA: Autophosphorylation of the PDGF receptor in the kinase insert region regulates interactions with cell proteins. Cell 58:1121, 1989
23. Pear WS, Nolan GP, Scott ML, Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90:8392, 1993
24. Anonymous: A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group [see comments]. Cell 72:971, 1993
25. Holtzman DA, Yang S, Drubin DG: Synthetic-lethal interactions identify two novel genes, SLA1 and SLA2, that control membrane cytoskeleton assembly in Saccharomyces cerevisiae. J Cell Biol 122: 635, 1993
26. Genpept an: celzk 370.3.
27. Rees DJ, Ades SE, Singer SJ, Hynes RO: Sequence and domain structure of talin. Nature 347:685, 1990
28. Velloso ER, Michaux L, Ferrant A, Hernandez JM, Meeus P, Dierlamm J, Criel A, Louwagie A, Verhoef G. Boogaerts M, Michaux JL, Bosly A, Mecucci C, Van den Berghe H: Deletions of the long arm of chromosome 7 in myeloid disorders: Loss of band 7q32 implies worst prognosis. Br J Haematol 92:574, 1996
29. Tosi S, Harbott J, Haas OA, Douglas A, Hughes DM, Ross FM, Blondi A, Scherer SW, Kearney L: Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH). Leukemia 10:644, 1996
30. Le Beau MM, Espinosa RR, Davis EM, Eisenbart JD, Larson RA, Green ED: Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood 88:1930, 1996
31. Fischer K, Frohling S, Scherer SW, McAllister Brown J, Scholl C, Stilgenbauer S, Tsui LC, Lichter P, Dohner H: Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood 89:2036, 1997
32. Duro D, Bernard O, Delia Valle V, Leblanc T, Berger R, Larsen CJ: Inactivation of the P16INK4/MTS1 gene by a chromosome translocation t(9;14)(p21-22:q11) in an acute lymphoblastic leukemia of B-cell type. Cancer Res 56:848, 1996
33. Grimwade D, Solomon E: Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia. Curr Top Microbiol Immunol 220:81, 1997